The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $61.01

Today's change-2.29 -3.62%
Updated May 1 4:00 PM EDT. Delayed by at least 15 minutes.
 

Magellan Health Inc

Nasdaq: MGLN
Last

(U.S.) $61.01

Today's change-2.29 -3.62%
Updated May 1 4:00 PM EDT. Delayed by at least 15 minutes.

Magellan Health Inc down (U.S.)$2.29

Magellan Health Inc closed sharply lower Friday, dropping (U.S.)$2.29 or 3.62% to (U.S.)$61.01. Shares have lost 14.30% over the last five days, but are unchanged over the last year to date. This security has underperformed the S&P 500 by 4.63% during the last year.

Key company metrics

  • Open(U.S.) $62.95
  • Previous close(U.S.) $63.30
  • High(U.S.) $63.08
  • Low(U.S.) $58.76
  • Bid / Ask-- / --
  • YTD % change+1.63%
  • Volume409,092
  • Average volume (10-day)191,141
  • Average volume (1-month)161,446
  • Average volume (3-month)161,608
  • 52-week range(U.S.) $52.37 to (U.S.) $71.83
  • Beta0.64
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward26.05×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$34.46
Updated May 1 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-24.18%

Magellan Health Inc has a net profit margin of -24.18%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.76%Sector:HealthcareIndustry:Managed Health Care
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Revenue981982923888
Total other revenue--------
Total revenue981982923888
Gross profit36614935
Total cost of revenue945922874853
Total operating expense1,938946898876
Selling / general / administrative--------
Research & development--------
Depreciation / amortization23242422
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total970------
Operating income-957362512
Interest income (expense), net non-operating-2-2-3-2
Gain (loss) on sale of assets--------
Other--------
Income before tax-958352211
Income after tax-96220264
Income tax, total415-36
Net income-96222275
Total adjustments to net income--------
Net income before extra. items-96222275
Minority interest0211
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-96222275
Inc. avail. to common incl. extra. items-96222275
Diluted net income-96222275
Dilution adjustment0--0--
Diluted weighted average shares26262728
Diluted EPS excluding extraordinary itemsvalue per share-36.450.821.000.18
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-36.450.821.000.18